Once Apo-AI is recognized by the SR-BI receptors at the tumor site, the HDL nanostructures trigger extracellular dissociation, releasing Apt-CpG-Dox into the tumor cell mesenchyme. This evidence concerns the gene APOA1 and neoplasm.